-
Notifications
You must be signed in to change notification settings - Fork 0
/
mysql_db.bak
88 lines (77 loc) · 5.68 KB
/
mysql_db.bak
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
-- MySQL dump 10.13 Distrib 5.6.33, for debian-linux-gnu (x86_64)
--
-- Host: localhost Database: HEALTHHACK_GP
-- ------------------------------------------------------
-- Server version 5.6.33-0ubuntu0.14.04.1
/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8 */;
/*!40103 SET @OLD_TIME_ZONE=@@TIME_ZONE */;
/*!40103 SET TIME_ZONE='+00:00' */;
/*!40014 SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0 */;
/*!40014 SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, FOREIGN_KEY_CHECKS=0 */;
/*!40101 SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='NO_AUTO_VALUE_ON_ZERO' */;
/*!40111 SET @OLD_SQL_NOTES=@@SQL_NOTES, SQL_NOTES=0 */;
--
-- Table structure for table `DRUG_GROUPS`
--
DROP TABLE IF EXISTS `DRUG_GROUPS`;
/*!40101 SET @saved_cs_client = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `DRUG_GROUPS` (
`group_name` varchar(255) NOT NULL,
`illegal_combination` varchar(255) DEFAULT NULL,
`priority` int(11) DEFAULT NULL,
PRIMARY KEY (`group_name`)
) ENGINE=InnoDB DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;
--
-- Dumping data for table `DRUG_GROUPS`
--
LOCK TABLES `DRUG_GROUPS` WRITE;
/*!40000 ALTER TABLE `DRUG_GROUPS` DISABLE KEYS */;
INSERT INTO `DRUG_GROUPS` VALUES ('Alpha-glucosidase inhibitor',NULL,6),('Biguanide',NULL,0),('DPP-4 inhibitor','Don\'t use with a GLP',2),('GLP1 analogue','Don\'t use with a DPP-4',4),('Insulin',NULL,5),('SGLT2 inhibitor',NULL,3),('Sulphonylurea',NULL,1),('Thiazolidinedione',NULL,7);
/*!40000 ALTER TABLE `DRUG_GROUPS` ENABLE KEYS */;
UNLOCK TABLES;
--
-- Table structure for table `DRUG_PROPERTIES`
--
DROP TABLE IF EXISTS `DRUG_PROPERTIES`;
/*!40101 SET @saved_cs_client = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `DRUG_PROPERTIES` (
`generic_name` varchar(255) NOT NULL,
`group_name` varchar(255) NOT NULL,
`CVD_rating` int(11) NOT NULL,
`CVD_notes` varchar(255) DEFAULT NULL,
`eGFR_contraindicated_cutoff` int(11) DEFAULT NULL,
`eGFR_30_60_notes` varchar(255) DEFAULT NULL,
`eGFR_30_notes` varchar(255) DEFAULT NULL,
`bowel_condition` tinyint(1) DEFAULT NULL,
`hypo_note` varchar(255) DEFAULT NULL,
`weightEffect` int(11) DEFAULT NULL,
`general_note_positive` varchar(255) DEFAULT NULL,
`general_note_negative` varchar(255) DEFAULT NULL,
PRIMARY KEY (`generic_name`),
KEY `fk_groupname` (`group_name`),
CONSTRAINT `fk_groupname` FOREIGN KEY (`group_name`) REFERENCES `DRUG_GROUPS` (`group_name`)
) ENGINE=InnoDB DEFAULT CHARSET=latin1;
/*!40101 SET character_set_client = @saved_cs_client */;
--
-- Dumping data for table `DRUG_PROPERTIES`
--
LOCK TABLES `DRUG_PROPERTIES` WRITE;
/*!40000 ALTER TABLE `DRUG_PROPERTIES` DISABLE KEYS */;
INSERT INTO `DRUG_PROPERTIES` VALUES ('acarbose','Alpha-glucosidase inhibitor',1,NULL,30,NULL,'contraindicated',1,NULL,1,NULL,NULL),('alogliptin','DPP-4 inhibitor',1,NULL,0,'reduce dose','reduce dose',0,NULL,1,NULL,NULL),('canagliflozin','SGLT2 inhibitor',1,NULL,45,NULL,'contraindicated',0,NULL,0,'positive impact on BP','increase risk of UTIs'),('dapaglifozin','SGLT2 inhibitor',1,NULL,60,NULL,'contraindicated',0,NULL,0,'positive impact on BP','increase risk of UTIs'),('empagliflozin','SGLT2 inhibitor',0,NULL,45,NULL,'contraindicated',0,NULL,0,'positive impact on BP','increase risk of UTIs'),('exenatide','GLP1 analogue',1,NULL,30,NULL,'contraindicated',1,NULL,0,NULL,NULL),('glibenclamide','Sulphonylurea',1,'increased risk as monotherapy',0,NULL,'increases risk of hypoglycemia',0,'hypoglycemia risk',2,NULL,NULL),('gliclazide','Sulphonylurea',1,'increased risk as monotherapy',0,NULL,'increases risk of hypoglycemia',0,'lowest hypoglycemia risk',1,NULL,NULL),('glimepiride','Sulphonylurea',1,'increased risk as monotherapy',0,NULL,'increases risk of hypoglycemia',0,'hypoglycemia risk',2,NULL,NULL),('glipizide','Sulphonylurea',1,'increased risk as monotherapy',0,NULL,'increases risk of hypoglycemia',0,'hypoglycemia risk',2,NULL,NULL),('insulin','Insulin',1,NULL,0,NULL,'hypoglycemia risk increases',0,NULL,2,NULL,NULL),('linagliptin','DPP-4 inhibitor',1,NULL,0,'reduce dose',NULL,0,NULL,1,NULL,NULL),('liraglutide','GLP1 analogue',0,NULL,30,NULL,'contraindicated',1,NULL,0,NULL,NULL),('metformin','Biguanide',1,NULL,30,'reduce dose','contraindicated',1,NULL,1,NULL,NULL),('pioglitazone','Thiazolidinedione',3,NULL,0,NULL,NULL,0,NULL,2,NULL,'increased risk of fractures (women) and bladder cancer'),('rosiglitazone','Thiazolidinedione',3,NULL,0,NULL,NULL,0,NULL,2,NULL,NULL),('saxagliptin','DPP-4 inhibitor',2,'may increase heart failure',0,'reduce dose','reduce dose',0,NULL,1,NULL,NULL),('sitagliptin','DPP-4 inhibitor',1,NULL,0,'reduce dose','reduce dose',0,NULL,1,NULL,NULL),('slow release gliclazide','Sulphonylurea',1,'increased risk as monotherapy',0,NULL,'increases risk of hypoglycemia',0,'hypoglycemia risk',2,NULL,NULL),('slow release metformin','Biguanide',1,NULL,30,'reduce dose','contraindicated',1,NULL,1,NULL,NULL),('vildagliptin','DPP-4 inhibitor',1,NULL,0,'reduce dose','reduce dose',0,NULL,1,NULL,NULL);
/*!40000 ALTER TABLE `DRUG_PROPERTIES` ENABLE KEYS */;
UNLOCK TABLES;
/*!40103 SET TIME_ZONE=@OLD_TIME_ZONE */;
/*!40101 SET SQL_MODE=@OLD_SQL_MODE */;
/*!40014 SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS */;
/*!40014 SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS */;
/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
/*!40111 SET SQL_NOTES=@OLD_SQL_NOTES */;
-- Dump completed on 2016-10-16 6:30:21